ArticleTherapeutic advances in medical oncology2026
Long-term comparative effectiveness of tepotinib versus standard of care for MET exon 14 skipping-mutated non-small cell lung cancer.
Joo-Young Byun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.